Your email has been successfully added to our mailing list.

×
0 -0.096 -0.0299999999999999 -0.0299999999999999 -0.0499999999999999 -0.0509999999999999 -0.049 -0.039999
Stock impact report

SAB Biotherapeutics Announces Progress on U.S. FDA’s Phased Review of Company’s Groundbreaking DiversitAb™ Platform

SAB Biotherapeutics, Inc. (SABS) 
Company Research Source: GlobeNewswire
-  FDA has approved five of seven sections in a rolling submission required for a New Animal Drug Application (NADA) for Company’s antibody generating DiversitAb™ platform in Transchromosomic (Tc) Bovine™ -  Announcement further solidifies SAB leading position in delivering, fully-human high-potency target-specific multi-epitope binding immunoglobulin (hIgG) antibody treatments without the need for human donors SIOUX FALLS, S.D., May 09, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (SAB, Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted fully-human multi-epitope binding immunoglobulin (hIgG) antibodies, also known as fully-human polyclonal antibodies, without the need for human donors, today announced the U.S. Food and Drug Administration has approved five of seven sections required for the Company’s pending New Animal Drug Application (NADA) for the company’s antibody-generating platform in Tr Show less Read more
Impact Snapshot
Event Time:
SABS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SABS alerts
Opt-in for
SABS alerts

from News Quantified
Opt-in for
SABS alerts

from News Quantified